Skip to main content

Table 1 Clinicopathological parameters of patients, with respectively good and bad outcome

From: Molecular markers associated with outcome and metastasis in human pancreatic cancer

Category Gender Age Location pG pT pN pM pR PNI LVI VI Postop OS DFS
GOOD F 55 Head 2 2 0 0 0 1 0 1 0 156.4 156.4
GOOD M 32 Head 3 3 1 0 0 1 1 0 RCT 127.9 127.9
GOOD M 78 Head 1 3 0 0 0 0 1 0 0 71.5 71.5
GOOD M 53 Head 3 3 1 0 0 1 0 1 RCT 67.2 67.2
GOOD F 61 Head 3 3 0 0 0 1 0 1 0 56.4 56.4
GOOD F 62 Head 3 3 1 0 0 0 0 1 RCT 62.7 62.7
GOOD M 68 Tail 3 2 0 0 0 1 0 1 CT 51.5 51.5
BAD F 75 Head 3 3 0 0 0 1 0 0 0 9.4 5.2
BAD M 72 Head 2 3 1 0 0 1 1 1 CT 12.6 5.6
BAD M 52 Head 3 3 0 0 0 1 0 1 0 8.4 4.1
BAD F 78 Head 2 3 1 0 0 1 1 1 0 9.9 3.6
BAD M 59 Head 3 3 1 0 0 1 0 0 0 6.3 2.8
BAD F 51 Head 3 3 0 0 0 0 0 0 CT 19.4 6.5
BAD M 74 Tail 3 1 1 0 0 1 1 1 CT 12.3 0.5
BAD M 50 Head 2 2 1 0 0 1 1 1 CT 9.4 7.0
BAD(M) M 67 Head     1      CT 8.3 /
  1. F: female; M: male; pG: pathological tumour grade; pT: pathological tumour size; pN: pathological lymph node status; pM: pathological metastasis; pR: pathological resection margin; PNI: perineural invasion; VI: vascular invasion; LVI: lymphovascular invasion; RCT: radiochemotherapy; CT: chemotherapy; OS: overall survival; DFS: disease-free survival.